Related Experiment Video
Updated: Aug 29, 2026
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines
Luigi Aloj1, Antonella Zannetti, Corradina Caracó
1Istituto di Biostrutture e Bioimmagini, Sezione di Bioimmagini, Consiglio Nazionale delle Ricerche (CNR), Via S. Pansini 5, Edificio 10, 80131 Napoli, Italy.
Abstract:
We have previously shown a correlation between the absence of technetium-99m methoxyisobutylisonitrile ((99m)Tc-MIBI) uptake and overexpression of the anti-apoptotic protein Bcl-2 in human breast carcinoma. To establish a direct cause-effect relationship between Bcl-2 overexpression and reduced (99m)Tc-MIBI uptake, MCF-7 and T47D breast cancer cell lines were stably transfected with the human Bcl-2 gene to increase intracellular protein levels and tested for (99m)Tc-MIBI uptake. All clones overexpressing Bcl-2 showed a dramatic reduction of (99m)Tc-MIBI uptake as compared with mock transfected control cells. Tracer uptake was promptly and partially restored by induction of apoptosis with staurosporine treatment. After 4.5 h of staurosporine treatment, a tenfold increase in (99m)Tc-MIBI uptake was observed in treated as compared with untreated Bcl-2 overexpressing cells. Our findings provide a rational basis for the development of an in vivo test to detect Bcl-2 overexpression in human tumours.
Insights
Overexpression of the anti-apoptotic protein Bcl-2 in breast cancer cells significantly reduces technetium-99m methoxyisobutylisonitrile ((99m)Tc-MIBI) uptake. Apoptosis induction partially restored this uptake, suggesting a potential diagnostic test.
Area of Science:
- Oncology
- Molecular Biology
- Nuclear Medicine
Background:
- A previous study indicated a correlation between reduced technetium-99m methoxyisobutylisonitrile ((99m)Tc-MIBI) uptake and Bcl-2 overexpression in human breast carcinoma.
- Bcl-2 is an anti-apoptotic protein implicated in cancer progression and treatment resistance.
Purpose of the Study:
- To establish a direct cause-effect relationship between Bcl-2 overexpression and diminished (99m)Tc-MIBI uptake in breast cancer cells.
- To investigate the impact of apoptosis induction on (99m)Tc-MIBI uptake in Bcl-2 overexpressing cells.
Main Methods:
- Stable transfection of MCF-7 and T47D breast cancer cell lines with the human Bcl-2 gene to overexpress intracellular Bcl-2 protein.
- Measurement of (99m)Tc-MIBI uptake in Bcl-2 overexpressing cells and mock-transfected controls.
- Induction of apoptosis using staurosporine and subsequent assessment of (99m)Tc-MIBI uptake.
Main Results:
- Clones overexpressing Bcl-2 exhibited a significant reduction in (99m)Tc-MIBI uptake compared to control cells.
- Apoptosis induction via staurosporine treatment led to a prompt and partial restoration of (99m)Tc-MIBI uptake.
- A tenfold increase in (99m)Tc-MIBI uptake was observed in Bcl-2 overexpressing cells after 4.5 hours of staurosporine treatment.
Conclusions:
- Bcl-2 overexpression directly causes reduced (99m)Tc-MIBI uptake in breast cancer cells.
- The findings support the development of an in vivo diagnostic test to detect Bcl-2 overexpression in human tumors using (99m)Tc-MIBI.
- This research provides a molecular basis for understanding (99m)Tc-MIBI uptake mechanisms in cancer.
